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Abstract 
Cellular thiols are critical moieties in signal transduction, regulation of gene 
expression, and ultimately are determinants of specific protein activity. Whilst 
protein bound thiols are the critical effector molecules, low molecular weight 
thiols, such as glutathione, play a central role in cytoprotection through (1) 
direct consumption of oxidants, (2) regeneration of protein thiols and (3) 
export of glutathione containing mixed disulphides. 
The brain is particularly vulnerable to oxidative stress, as it consumes 20% of 
oxygen load, contains high concentrations of polyunsaturated fatty acids and 
iron in certain regions, and expresses low concentrations of enzymic 
antioxidants. There is substantial evidence for a role for oxidative stress in 
neurodegenerative disease, where excitotoxic, redox cycling and mitochondrial 
dysfunction have been postulated to contribute to the enhanced oxidative load. 
Others have suggested that loss of important trophic factors may underlie 
neurodegeneration. However, the two are not mutually exclusive; using cell 
based model systems, low molecular weight antioxidants have been shown to 
play an important neuroprotective role in vitro, where neurotrophic factors 
have been suggested to modulate glutathione levels. 
Glutathione levels are regulated by substrate availability, synthetic enzyme and 
metabolic enzyme activity, and by the presence of other antioxidants, which 
according to the redox potential, consume or regenerate GSH from its oxidised 
partner.  
Therefore we have investigated the hypothesis that amyloid beta neurotoxicity 
is mediated by reactive oxygen species, where trophic factor cytoprotection 
against oxidative stress is achieved through regulation of glutathione levels.  
Using PC12 cells as a model system, amyloid beta 25-35 caused a shift in DCF 
fluorescence after four hours in culture. This fluorescence shift was attenuated 
by both desferioxamine and NGF. After four hours, cellular glutathione levels 
were depleted by as much as 75%, however, 24 hours following oxidant 
exposure, glutathione concentration was restored to twice the concentration 
seen in controls. NGF prevented both the loss of viability seen after 24 hours 
amyloid beta treatment and also protected glutathione levels.  NGF decreased 
the total cellular glutathione concentration but did not affect expression of 
GCS.  
In conclusion, loss of glutathione precedes cell death in PC12 cells. However, 
at sublethal doses the surviving fraction respond to oxidative stress by 
increasing glutathione levels, where this is achieved, at least in part, at the gene 
level through upregulation of GCS. Whilst NGF does protect against oxidative 
toxicity, this is not achieved through upregulation of GCS or glutathione. 
 
Introduction 
Increasing age is the most reliable and robust risk factor for susceptibility to 
neurodegenerative disease (Bains & Shaw, 1997).  Lovell et al., (1995) showed 
support for the concept that the brain in Alzheimer’s disease (AD) is under 
increased oxidative stress (OS) demonstrating lipid peroxidation changes in 
areas where degenerative changes occur.  Further evidence suggesting that the 
pathogenesis of AD is as a result of oxidative damage includes elevated levels 
of iron in AD brains and a colocalised reduction in antioxidant status (Good et 
al., 1996). Whilst the exact mechanisms underlying oxidative stress remain 
unclear, it has been proposed that the peptidergic fragment of amyloid beta 
(Aβ) that accumulates in AD may exert its toxicity through peroxide 
generation (Huang et al., 1999).   
 
Glutathione is arguably the most important AOX and free radical scavenger 
present in cells (Valencia et al., 2001), where glutathione-associated 
metabolism is a major mechanism for cellular protection against agents that 
generate OS. Glutathione participates in detoxification at several different 
levels, and may scavenge reactive oxygen species (ROS), reduce peroxides, or 
be conjugated with electrophilic compounds.  Thus, glutathione provides the 
cell with multiple defences not only against ROS but also against their toxic 
products.  Most importantly, many of the glutathione-dependent proteins are 
inducible and therefore represent a means whereby cells can adapt to OS 
(Hayes & McLellan, 1999). The GSH redox status is critical for various 
biological events that include transcriptional activation of specific genes, 
modulation of redox-regulated signal transduction, regulation of cell 
proliferation, apoptosis, and inflammation (Rahman & MacNee, 2000).  In 
addition, it has been shown previously that GSH levels decrease following 
addition of cytotoxic agents, and at the time of onset of apoptosis (van den 
Dobbelsteen et al., 1996; Froissard & Duval, 1994).   
 
The intracellular synthesis of GSH is mainly regulated by gamma glutamyl 
cysteinyl synthetase (γ-GCS) (Richman & Meister, 1975). Differences or 
alterations in the levels of protein can occur by a number of different 
mechanisms including alterations in the level of gene transcription and 
alterations in the stability or translatability of the resulting RNA. The 
expression of γ-GCS is sensitive to OS, where the existence of the OS-response 
element, AP-1, on the γ-GCSh (g-GCS heavy subunit) promoter has been 
clarified (Mulcahy et al.,1997).  
 
Maintenance of a high intracellular (GSH)/(GSSG) ratio (>90%) minimises the 
accumulation of disulfides and provides a reducing environment within the 
cell.  If there is a shift in the GSH/GSSG redox buffer, a variety of cellular 
signalling processes are influenced, such as activation and phosphorylation of 
stress kinases (JNK, p38, PI-3K) via sensitive cysteine-rich domains; 
activation of sphingomyelinase-ceramide pathway, and activation of the 
transcription factors AP-1 and NF-κB, eventually leading to increased gene 
transcription (Rahman &  MacNee, 2000). 
 
Froissard et al., (1997) have reported that there is strong evidence to support 
the existence of a close relationship between the level of intracellular 
glutathione and cell survival in PC12 cells, where mitochondrial GSH is 
critical for the maintenance of mitochondrial function and cellular viability 
(Seyfried et al., (1999).  However, whether a drop in GSH levels precede 
intracellular ROS production during apoptosis or vice versa is not certain. 
Hence any role of GSH depletion alone in triggering apoptosis is not clear 
(Hall, 1999).  
 
Evidence is accumulating for an important role for glutathione in detoxification 
processes in the brain. Depletion of glutathione in newborn rats using 
buthionine sulfoximine (BSO) leads to mitochondrial damage in the brain (Jain 
et al , 1991). Furthermore, application of beta amyloid peptide, glutamate 
receptor agonists and BSO cause GSH depletion in cultured neurones and lead 
to induction of apoptosis. H2O2 has previously been suggested to mediate Aβ 
cytotoxicity based on antioxidant inhibition of toxicity and demonstration of 
lipid peroxidation in treated cells (Behl et al., 1994b). The toxic effects of 
several other ROS generating compounds has been shown to be abrogated by 
neurotrophic factors such as BDNF, NGF, GDNF and bFGF (Cheng and 
Mattson, 1995; Chao and Lee). It has been postulated that this may be due to 
upregulation of the concentration of glutathione and/or the activities of 
antioxidant enzymes.  
 
Therefore we have investigated the hypothesis that Aβ neurotoxicity is 
mediated by reactive oxygen species, where trophic factor cytoprotection 
against oxidative stress is achieved through regulation of glutathione levels at 
the gene level. Herein, we demonstrate that Aβ  toxicity is associated with 
alterations in cellular redox status, and whilst NGF affords protection against 
toxicity, this is independent of GCS expression.  
 
 
Methods 
Maintenance of PC12 cell line 
PC12 cells were routinely cultured in 75cm2 flasks in a water jacketed 
humidified 5% CO2 incubator with maintenance media.  (RPMI 1640 media 
with Glutamax I; 10% (v/v) HS, 5% (v/v) FBS, penicillin (0.5U/ml) and 
streptomycin (0.5mg/ml).  Every 2-3 days, spent PC12 cell media was removed 
and replaced with fresh maintenance media, which had been pre-warmed to 
37°C.  Cells were passaged once a week, as described in section 2.2.1.3, when 
the cells were at a density of approximately 5 x 106 per ml. For experimental 
purposes, cells were seeded at 2 x 105 cells per ml and allowed to rest for 4 
hours prior to treatment for times and doses indicated. 
Determination of cell viability using 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium (MTT) assay  
Cells (2 x 105 cells per ml, 100µl per well) were seeded into 96 well flat 
bottomed microtitre plates.  Two hours prior to completion of the experiment, 
MTT solution (25µl of 5mg/ml in 0.01M PBS) was added to all wells 
including blanks.  Plates were then incubated for a further 2 hours at 37°C, 5% 
CO2.  Lysis buffer (100µl of 20% w/v SDS, in DMF (50%), dH2O(50%), pH 
4.7 adjusted with 2.5% of 80% glacial acetic acid) was then added to each well 
and the plates incubated for a further 16 hours at 37°C, 5%CO2.  The 
absorbance of the each well was then read at 570nm in a 96 well plate reader. 
Dichlorofluorescein diacetate (DCFDA) staining 
Cells (2 x 105 per ml, 2ml) were incubated with test agents in 35mm well 
plates.  30 minutes before the end of incubation, DCFDA solution (20µl of 
7.5mM diluted stock in PBS) was added to the plates.  After exactly 30 
minutes cells were immediately harvested with a Gilson pipette and a rubber 
policeman and transferred to a flow cytometry tube.  Samples were then 
immediately run through a Coulter EPICS flow cytometer with the intensity of 
light scatter and the FL1 fluorescence emitted between 505 and 535nm 
following excitation at 488nm (argon laser) was recorded for individual 
nucleoids.  The median X was calculated for 10,000 nucleoid events. 
Glutathione (GSH) Assay 
Glutathione (reduced and oxidised) levels were determined using modified 
microtitre plate method (Punchard et al., 1994).  Actual glutathione levels were 
calculated by equating the changes in absorbance over time alongside 
standards of known GSH concentrations included on each plate. Glutathione 
(GSH), reduced standards were freshly prepared for each experiment from a 
stock (100mM in sterile distilled water). Cells (2x105) were then harvested and 
PBS (1ml) added to wash the pellet.  Tubes were recentrifuged at 6600 x g for 
1.5 minutes and the PBS was then removed, making sure to leave the pellet 
dry.  SSA (3.33µl of 1% made up in distilled water) was then added to 
precipitate the protein and the tubes were immediately centrifuged at 13000 x g 
for 1.5 minutes.  Stock buffer (96.6µl of 125mM sodium phosphate, 6.3mM 
disodium EDTA, pH 7.5 autoclaved) was then added to each tube.  Standards 
and samples (25µl) were then aliquoted into a flat bottomed plates (96 well) in 
triplicate, the remaining aliquot was immediately frozen at -70°C for later use 
in the GSSG assay.  Daily buffer (150µl of 0.3mg NADPH/ml stock buffer) 
and DTNB solution (50µl of 6mM DTNB in daily buffer) was then added to all 
wells.  The plate was then loaded onto the carriage of a 96 well plate reader 
and glutathione reductase solution (25µl of 20U/ml) was then added as quickly 
as possible to initiate the reaction.  The OD was then recorded every minute for 
5 minutes at 410nm. 
Glutathione (GSSG) Assay 
Oxidised glutathione (GSSG) standards were freshly prepared for each 
experiment from an oxidised glutathione stock (1.5µM in sterile distilled 
water). 
The remaining 25µl aliquot from the GSH assay was employed for this assay.  
To the frozen aliquot and standards (25µl), 2-vinylpyridine (2-VP), 
triethanolamine (0.5µl) were added.  Samples and standards were then 
vortexed and centrifuged for 30 seconds at 13000 x g.  Aliquots of standards 
and samples (10µl) were then plated out into a microtitre plate (96 well plate).  
Daily buffer (75µl of 0.3mg NADPH/ml stock buffer) and DTNB solution 
(25µl of 6mM DTNB in daily buffer) were added to the wells.  The plate was 
then loaded onto the carriage of a 96 well plate reader and glutathione 
reductase solution (12.5µl of 20U/ml) was then added as quickly as possible to 
initiate the reaction.  The OD was then recorded every minute for 5 minutes at 
410nm.  
Estimation of Protein Concentration 
Protein concentrations were assessed according to a modified version of Sigma 
Procedure No. TPRO-562, based on the method of Smith et al, (1985).  Protein 
standards of six concentrations were prepared from the protein standard 
solution (bovine serum albumin, 1mg/ml) diluted in coating buffer (15mM 
sodium carbonate, 35mM sodium hydrogen carbonate, pH 9.2). Each standard 
(10µl) was plated out in triplicate into a 96 well flat bottomed microtitre plate.  
Unknown samples (10µl) were also plated out in triplicate.  Bicinchoninic acid 
solution (200µl) containing copper (II) sulphate pentahydrate 4% solution 
(50:1) was then added to all wells (samples and standards), the plate was then 
incubated at 37°C for 30 minutes.  The absorbance of the plate was then 
measured at 570nm in a 96 well plate reader. Unknowns were calculated from 
a standard curve prepared using the software package GraphPad PRISM.   
mRNA EXTRACTION 
Cells (2x105) were harvested into a RT grade centrifuge tube (1.5ml).  Cells 
were centrifuged for 1.5minutes at 13000 x g in an Eppendorf Centrifuge 
5415D.  Supernatants were removed and PBS (1ml) added, cells were 
centrifuged for another 1.5minutes at 13000 x g and the PBS removed.  The 
extraction was carried out using the Dynal mRNA direct kit protocol.   Pellets 
were resuspended into 200µl Dynal lysis/binding buffer (100mM Tris-HCl, pH 
7.5, 500mM LiCl, 10mM EDTA, pH8.0, 1% LiDS and 5mM DTT) and 
aspirated twenty times to fully resuspend each pellet with fresh tips being used 
for each tube.  The solution was then aspirated five times using 1ml sterile 
syringes and sterile 21 gauge needles to shear the DNA.  This was then 
repeated using 1ml sterile syringes and sterile 25 gauge needles.  Tubes were 
then centrifuged for 1 minute at 13000 x g in an Eppendorf Centrifuge 5415D.  
Resuspended Dynal Oligo (dT)25 beads (30µl) were washed in Dynal 
lysis/binding buffer twice before being added to each tube of lysed cells.  The 
tubes were then mixed on a Dynal sample mixer for 5 minutes at 22-25°C.  
Tubes were then magnetised on the Dynal MPC-E magnet (Magnetic particle 
concentrator for microtubes of Eppendorf type (1.5ml)) and the colourless 
solution removed.  Dynal wash buffer A (200µl of 10mM Tris-HCl, pH 7.5, 
0.15M LiCl, 1mM EDTA, 0.1% LiDS) was then added to the pellet and the 
cells resuspended in it.  The tubes were then remagnetised the colourless 
solution removed and Dynal wash buffer A added (200µl) and the cells 
resuspended.  The process was then repeated using Dynal wash buffer B 
(200µl of 10mM Tris-HCl, pH 7.5, 0.15M LiCl, 1mM EDTA).  After two 
washes with wash buffer B the cell pellet was resuspended in DEPC treated 
water (30µl of 0.1%).  This was then transferred to a fresh tube (1.5ml), and 
master mix was added (39µl of 10mM DTT (7.5µl of 100mM), 1mM dNTPs 
(7.5µl dNTP mix), 25U RNAsin (1.8µl), 1U (3µl) RQ1 RNase-free DNase, 
0.1% DEPC treated water (4.2µl) and Expand buffer (15µl)).  Each tube was 
aspirated twice and incubated at 37°C for 60 minutes.  DNase was heat 
inactivated at 70°C for 10 minutes in a preheated dry heating block.  Samples 
were then centrifuged at 13000 x g for 1 minute in an Eppendorf centrifuge 
5415D. 
Reverse transcription of mRNA 
Two RT grade PCR tubes were labelled for each sample, one positive and one 
negative.  RNAsin 15U (1µl) was added to the negative tubes and 30U (2µl) to 
the positive tubes, mRNA extraction product (46µl) was added to the positive 
tubes and mRNA extraction product (23µl) was added to the negative tubes.  
Expand RT 50U, (1µl) was then added to the positive tubes.  For reverse 
transcription mRNA was incubated at 37°C for 1 hour in Expand RT buffer 
containing 10mM DTT, 1mM dNTPs, 25U RNAsin, 1U RQ1 RNase-free 
DNase.  DNase was heat inactivated at 70°C for 10 minutes.   The samples 
were then incubated at 42°C for 1 hour before being stored in the short term at 
0 - 4°C, and at -20°C in the long term. 
Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) and GCS 
polymerase chain reaction (PCR) 
The primers (50nmol of each) as stated in table 2.4 were synthesised by 
Gibco/BRL, Life Technologies, Paisley, Scotland.  Each primer was diluted to 
100 pmol/µl in sterile 1 x TE buffer (10mM Tris, 1mM EDTA, pH 8.0), and 
then further diluted tenfold in 1 x TE buffer and stored as 10µl aliquots at -
20°C. 
Primer Sequences 
Primer Forward primer 
sequence (5’ – 3’) 
Reverse primer 
sequence (5’-3’) 
Reference 
GAPDH AGA ACA TCA TCC 
CTG CCT C 
GCC AAA TTC GTT 
GTC ATA CC 
Hall et al., 1998 
GCS CCT TCT GGC ACA 
GCA CGT TG 
TAA GAC GGC ATC 
TCG CTC CT 
El Mouatassium 
et al., 2000 
PCR was performed in PCR buffer with sterile water, 200mM dNTPs and 
10pmol of each primer.  All reactions were covered in a drop of mineral oil and 
hot start conditions were used, full details of each PCR as stated in table 2.5.  
Reactions were initiated with 2.5U (0.5µl) Taq DNA Polymerase.  All liquid 
handling was conducted using filter tips. 
 Optimal PCR Conditions 
PRIMER CONDITIONS CYCLES 
GAPDH 98°C   3 minutes  
+ Taq 
60°C   2 minutes 
72°C   2 minutes 
………………………………… 
94°C   30 seconds 
60°C   30 seconds 
72°C   30 seconds 
………………………………… 
94°C   30 seconds 
60°C   30 seconds 
72°C   4 minutes       
    
1 cycle 
 
 
 
26 cycles 
 
 
 
 
1 cycle 
GCS 94°C   1 minute 
94°C   45 seconds  
+ Taq 
56°C   1 minute 
72°C   1 minute 
…………….……….………… 
94°C   45 seconds 
56°C   1minute 
72°C   1minute 
………………………….……. 
72°C   10 minutes          
1 cycle 
 
 
 
 
 
31 cycles 
 
 
 
 
1 cycle 
 
Agarose gel electrophoresis of PCR products 
Gel loading solution (2.5µl of 0.05% w/v bromophenol blue, 40% w/v sucrose, 
0.1M EDTA, pH 8.0) was added to the PCR reaction products (10µl).  Samples 
were loaded onto 1.5% agarose gels made up in 1 x TBE (89mM Tris, 89mM 
boric acid, 2.5mM EDTA, pH 8.0, 100ml Gel).  Gels were electrophoresed at 
80V for 2 hours in 350ml 1 x TBE.  Post staining was achieved with ethidium 
bromide (10µl of a 10mg/ml solution) dissolved into 100ml of distilled water 
for 15 minutes in the dark at 22 - 25°C.  Gels were visualised on an U.V. 
transilluminator table at 312nm.  Expression levels were quantitated using the 
software package Phoretix 1D Advanced, Version 4.01 (Non Linear Dynamic 
Limited) and normalised to GAPDH.   Gels were all loaded with a size ladder, 
usually a 123bp DNA ladder prepared according to manufacturer’s 
instructions. 
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Results 
It has been proposed that Aβ may exert its toxicity through peroxide 
generation.  In order to confirm whether generation of ROS occurs in PC12 
cells and whether these levels are modulated by exogenous agents, the effects 
of Aβ on intracellular peroxide levels were investigated in PC12 in the 
presence and absence of NGF. PC12 cells were incubated with NGF (5 and 
10ng/ml) for 24 hours before addition of Aβ (25µM) and the fluorochrome 
DCFDA.  Cells were harvested and immediately analysed through a flow 
cytometer. Exposure of PC12 cells to Aβ 25-35 (10µM) caused an increase in 
intracellular peroxide which was evident after 4 hours. Production of 
intracellular peroxide was inhibited by either desferioxamine or NGF 
(10ng/ml), where NGF had no effect on basal cellular peroxide in control cells 
(see Figure 1). Pre-treatment with 5ng/ml NGF prior to Aβ elicited a decrease 
in the median X value for DCF fluorescence to 0.300, indicative of a decrease 
in intracellular peroxide concentration (data not shown).     
 
Figure 1. PC12 cells (2x105) were incubated for 4 hours at 37°C, 5%CO2 
before the addition of NGF (10ng/ml) or DFX (100uM) for 24 hours at 
37°C, 5%CO2.  Aβ (25µM) was then added for 4 hours at 37°C, 5%CO2.  
For the final 30 minutes of incubation, DCFDA (75µM) was added.  Cells 
were then harvested and analysed by flow cytometry.  Figure shows the 
average median X ± SEM.  
 
In order to establish whether intracellular ROS production was associated with 
a reduction in cell viability, MTT reductive capacity was investigated after 
exposure to Aβ or H2O2. In the absence of NGF, Aβ  (10µM) caused a 25% 
reduction in MTT reductive capacity after 24 hours treatment, and this effects 
was not enhanced by higher peptide concentrations.  Much higher 
concentrations of hydrogen peroxide were required to elicit the same loss of 
viability; after 24hours treatment with 150µM H2O2, MTT reductive capacity 
was reduced by 23% (Figure 2a and 2b).  
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Figure 2a The effects of amyloid β (25-35) toxicity on PC12 cells.  
PC12 cells (2x105) were incubated with aged Aβ (10, and 25µM) for 24 
hours at 37°C, 5% CO2.  Cells were then subject to the MTT assay.  
Graph shows the mean absorbance of formazan produced ± SEM for at 
least 3 replicates.  ** represents P<0.01 (Dunnett’s test). 
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Figure 2b The effect of hydrogen peroxide on PC12 cell viability using 
the MTT assay.  PC12 cells (2 x 105) were incubated for 4 hours at 37°C, 
5% CO2 before the addition of H2O2 (50, 100, and 150µM) for 24 hours at 
37°C, 5% CO2. Cells were then subject to the MTT assay.  Data shown are 
the mean absorbance of formazan produced ± SEM of 6 replicates for 
each treatment.  ** represents P values of <0.01 (Dunnett’s test). 
 
Previously, others have shown that NGF is an effective cytoprotectant against 
oxidative toxicity arising from glutamate or dopamine. However, this has not 
been shown for hydrogen peroxide or amyloid beta. Figure 3 demonstrates that 
NGF affords protection to PC12 cells against peroxide toxicity, when cells 
have been previously exposed to 5 or 10ng/ml NGF prior to oxidant challenge. 
Higher doses of NGF (50ng/ml) exerted a cytotoxic effect (data not shown).  
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Figure 3 The effects of nerve growth factor on PC12 cell viability in 
the presence or absence of H2O2.  PC12 cells (2 x 105) were incubated with 
NGF (5 and 10ng/ml) for 24 hours at 37°C, 5% CO2.  H2O2 (150µM) was 
then added for a further 24 hours at 37°C, 5% CO2.  Cells were then 
subject to the standard MTT assay.  Graph shows the mean absorbance of 
formazan produced ± SEM for at least 14 replicates.  
 
Glutathione participates in detoxification at several different levels, and can 
scavenge ROS and reduce peroxides. To determine whether intracellular 
protection is compromised by oxidative challenge, and to determine the 
kinetics of glutathione metabolism during 24hours of oxidative stress treatment 
elicited by either hydrogen peroxide or Aβ, total cellular glutathione was 
measured after 1, 4 and 24 hours. Figure 4 illustrates the rapid loss of 
intracellular GSH following addition of hydrogen peroxide to PC12 cells in 
culture, where levels reduced by 50% within one hour. In contrast, Aβ did not 
affect GSH levels until four hours after treatment. Nevertheless, Aβ  treatments 
did cause a twofold increase in total intracellular glutathione in the surviving 
cell population at 24 hours (p<0.05), where peroxide induced a highly 
significant fourfold increase in GSH (P<0.001).  Again after 24 hours peroxide 
treatment (160uM), there was a ten fold increase oxidised glutathione, but the 
concentration of GSSG only rose from 0.02% to 0.05% of total glutathione 
(data not shown). 
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Figure 4. Kinetics of hydrogen peroxide effects on glutathione levels in 
PC12 cells.  PC12 cells (2x105) were incubated with H2O2 (150 µM) for 0-
24 hours at 37°C, 5%CO2.  Figure shows the mean glutathione value ± 
SEM of 3 replicates.  *** represents P<0.005 (Bon Feronni test) 
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Figure  5.  The effects of amyloid β peptide on glutathione levels in PC12 
cells.  PC12 cells (2x105) were incubated with Aβ25-35 (10µM) for 0-24 
hours at 37°C, 5% CO2. Figure shows the mean glutathione value ± SEM 
of at least 4 replicates. * represents P<0.05 (Dunnett’s test) 
 
 
 
In order to determine whether part of the cytoprotective effects of NGF could 
be attributed to up-regulation of glutathione, the effects of NGF in the presence 
and absence of oxidant challenge on glutathione levels and on expression of 
GCS mRNA were examined. Figure 6 shows NGF to prevent the increase in 
GSH levels observed post- exposure to Aβ, where 10ng/ml NGF significantly 
reduced intracellular glutathione concentration after 4 and 24 hours 
respectively.  
 
Figure 6a The effects of nerve growth factor on amyloid β peptide induced 
changes to glutathione levels in PC12 cells.  PC12 cells (2x105) were 
incubated with NGF (10ng/ml) for 24 hours at 37°C, 5% CO2 before 
incubation with Aβ25-35 (10µM) for 0-24 hours at 37°C, 5% CO2. Figure 
shows the mean glutathione value ± SEM of at least 3 replicates. * 
represents P<0.05 (Unpaired t-test) 
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Figure 6b The effects of nerve growth factor on the action of hydrogen 
peroxide on glutathione levels in PC12 cells.  PC12 cells (2x105) were 
incubated with NGF (5 and 10ng/ml) for 24 hours at 37°C, 5%CO2 before 
addition of H2O2 (50, 100, 150µM) at 37°C, 5% CO for 24 hours2.  Figure 
shows the mean glutathione value ± SEM of 3 replicates. 
 
Analysis of GCS mRNA expression in PC12 cells exposed to oxidative stress 
in the presence or absence of NGF is shown in figure 7. In the absence of 
peroxide challenge, NGF elicited an increase in GCS mRNA expression after 
two hours in PC12 cells, whereas mRNA levels were essentially unchanged in 
the absence of NGF. However, when PC12 cells were subject to an oxidative 
challenge for 4 hours after 24hours pre-incubation with vehicle or NGF, cells 
showed reduced expression of GCS mRNA irrespective of the presence or 
absence of NGF. Furthermore, 24hours after oxidative challenge in the 
presence in NGF, GCS mRNA expression was restored to that seen prior to 
oxidative challenge. In contrast, PC12 cells subject to oxidative challenge in 
the absence of NGF showed up-regulation of GCS expression 24 hours post-
oxidative challenge, where image analysis using phoretix software 
demonstrated a twelve-fold increase in expression.  
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Figure  7.  1.5% Agarose gels of PCR products.  PC12 cells (2x105) were 
incubated with NGF (10ng/ml) or PBS as control for 0-24 hours at 37°C, 
5%CO2. H2O2 (150µM) was then added for 4 and 24 hours at 37°C, 
5%CO2 and cells were harvested and mRNA extracted. Folowing reverse 
transcription specific PCRs were underatkaen for GAPDH and GCS.     
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Discussion 
The levels of intracellular peroxide can be quantitated using the nonfluorescent 
fluorochrome 2’,7’-dichlorofluorescin diacetate (DCFDA) which is freely 
permeable to cells. It is de-esterified within cells by endogenous esterases to  
2’,7’-dichlorofluorescein (DCF).  This becomes trapped within cells and 
accumulated DCF is able to interact with peroxides and hydroperoxides in the 
cell to form the fluorescent compound 2’,7’-dichlorofluorescein (Behl et 
al.,1994a; Zhu et al., 1994). There is an important caveat to the successful use 
of DCF as a peroxide sensor, and that it is also a suitable substrate for direct 
oxidation by xanthine oxidase, where inhibition by allopurinol can be used to 
determine any role of the latter. 
 
 DCF staining has previously been shown to increase with ROS production 
(Satoh et al., 1997).  Addition of H2O2 increases intracellular peroxide in PC12 
cells (data not shown); this is in agreement with the work of other groups (Jang 
& Surh, 2001).  Herein, we have shown that Aβ increases intracellular 
peroxides. The inclusion of the iron chelator DFX suggests this process is iron 
dependent, and suggests that Aβ cannot exert its toxicity without the 
availability of iron.  These observations support the work of Monji  et al., 
(2002) who have demonstrated that Aβ (25-35)-associated free radical 
generation is iron dependent and strongly influenced by the aggregational state 
of the peptides. 
 
Whilst NGF pre-treatment in unchallenged cells did not cause any significant 
lowering of intracellular peroxide levels in PC12 cells, it was effective in 
preventing the elevation in cytoplasmic peroxide observed following amyloid 
beta challenge. Previously trophic factors have been shown to protect cells 
against ROS toxicity in cultured neurones and PC12 cells, however these 
papers did not measure intracellular ROS directly (Chang and Mattson; 1995; 
Gong et al, 1999). In addition, these earlier studies have investigated oxidative 
stressors implicated in the pathogenesis of Parkinson’s disease. Amyloid beta 
is implicated in cholinergic neurone loss in AD, and in our system, we have 
demonstrated the generation of ROS precedes cell death. Again, in our model, 
the toxic effects of amyloid beta were prevented by NGF. 
 
It has been postulated that the cytoprotective effect of trophic factors may be 
dependent on the upregulation of glutathione and/or enzymes associated with 
ROS defence. Examination of the effects of ROS on cellular glutathione 
confirmed the observations of others, that GSH is rapidly consumed, but then 
recovers to offer enhanced protection against further insults. OS appears to be 
a key pleiotropic modulator of gene transcription acting through the generation 
of bioactive mediators (Morel & Barouki, 1999).  The number of transcription 
factors whose activities are modulated by ROS is substantial, and include AP-
1, p53, NF-κB, HSF, Sp-1 and GABP (Kehrer, 2000).  In this respect, ROS 
appear to be actual modulators of gene transcription, independently of the 
degradation of biological macromolecules (Morel & Barouki, 1999). Therefore 
if ROS can induce an adaptive response, for example though induction of GCS, 
offering greater protection of the cell exposed to subsequent OS. 
 
In this paper, we report that NGF (10ng/ml) did not cause any significant 
changes in GSH levels of unchallenged cells; this is in agreement with Kamata 
et al., (1996) who showed NGF to protect cells from OS independently of 
GSH.  However under H2O2 and Aβ challenge, increased levels of GSH were 
recorded versus control after 24 hours, with NGF (10ng/ml) preventing the 
elevation induced by oxidative stress.  The data recorded with 5ng/ml NGF is 
consistent with the data previously published by Pan & Perez-Polo (1993) and 
Sampath et al., (1994) who have both shown NGF to cause increases in GSH 
levels.  GSSG levels were also assessed where H2O2 to caused increased GSSG 
concentration after challenge with 160uM peroxide.  Nevertheless, it is evident 
from this data that much of the GSH is lost particularly at early time points, 
either through mixed disulphide formation with proteins or through efflux. The 
drop in GSH may therefore reflect an inhibition of synthesis, a deficit in the 
GSH salvage pathway, or an increased rate of efflux (Chandra et al., 2000). In 
both scenarios, efficient removal of ROS and formation of GSSG is dependent 
on expression and activity of GPX, which in itself is redox sensitive, and the 
activity of the enzyme under oxidative stress. Specifically, the effect of NGF 
merits further investigation, since infusion of GDNF into the brain has been 
shown to increase the activity of GPx (Chao and Lee, 1999) 
 
Yonezawa et al., (1996) have shown that deprivation of one of the precursors 
of glutathione (cysteine) induces glutathione depletion and death in cultures of 
cells, but that rescue by free radical scavenger and a diffusible glial factor was 
not associated with a restoration of normal glutathione content.  These authors 
thus suggest that the protecting agents act distal to glutathione. This is in 
agreement with Kamata et al., (1996) who showed when cellular GSH was 
depleted by treatment with BSO, NGF still protected cells.  These data largely 
support the hypothesis that NGF exerts its protection independently of GSH.  
NGF (10ng/ml) does not to cause any significant increases in glutathione 
levels, however, does protect against intracellular ROS and also cell death. To 
further clarify whether NGF exerts its protection via glutathione up regulation, 
studies on GCS expression were undertaken.   
 
Cell cross-talk between glia and neurones appears critical to maintainence of 
neuronal viabililty. Glia conditioned medium has been shown to contain an 
unidentified diffusible factor which enhances resistance to oxidative stress by 
increasing transcription of GCS (Iwata-Ichikawa, 1999). In order to determine 
whether NGF can elicit a similar response in PC12 cells, we have evaluated 
GCS expression in PC12 cells, in relation to glyceraldehydes 3-phosphate 
expression (GAPDH). The glycolytic tetramer GAPDH/G3PDH is a 
multifunctional enzyme involved in cellular metabolism.  It is an important 
glycolytic enzyme that catalyses the oxidative phosphorylation of 
glyceraldehyde-3-phosphate to 1,3-diphosphoglycerate, and it is the most 
widely used internal control gene  (Suzuki et al., 2000).  Measurement of 
GAPDH transcript abundance was originally selected as a normalizer for other 
expressions because it encodes for a protein with a housekeeping function.  As 
it is a glycolytic intermediate it is therefore expected to be present in all cells 
and exhibit minimal modulation.  However GAPDH gene expression has been 
reported to increase during other non-glycolytic activities such as programmed 
neuronal cell death (Ishitani et al., 1996).   
During investigations into selective GCS gene expression, GAPDH expression 
remained constant.  GCS expression was more variable in NGF treated cells 
compared to non-NGF treated cells.  The only marked differences in non NGF 
treated cells were after 4 hours of peroxide challenge where expression was 
virtually nothing and after 24 hours of peroxide challenge where there was the 
greatest expression.  In NGF treated cells GCS levels initially increased up to 2 
hours after the NGF treatment then decreased.  After 4 hours of peroxide 
challenge GCS levels were also greatly reduced showing the least expression, 
expression then increased after 24 hours of peroxide challenge. Tubulin is 
frequently used as a housekeeping gene for neuronal studies, however, 
transcription of this species is itself affected by the onset of apoptosis, 
rendering it a poor control gene. 
 
One of the most variable factors appears to lie in the variation in GSH levels 
within resting cells. Indeed, GSH levels have also been shown to decrease in 
culture imposing the need for consistent experimental conditions (Reiners Jr et 
al., 2000), including passage frequency and seeding density.  
 
There is a poor correlation between mRNA and protein levels, as the presence 
of RNA in a cell is not necessarily indicative of peptide synthesis.  Structurally 
authentic mRNAs may be poorly handled by the translational machinery in a 
cell.  Even the efficient translation of a functional message may not result in 
biologically active peptide if post translational processes are absent, or if the 
peptide is rapidly degraded.  The analysis of GCS gene expression must 
therefore extend to the description of the protein end-points of the expression 
pathway, included in this must be a consideration of protein function (Carter & 
Murphy, 1999).  
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